AI ultrasound could revolutionize breast cancer screening in Low-Resource areas
NCT ID NCT07462351
First seen Mar 20, 2026 · Last updated Jun 05, 2026 · Updated 7 times
Summary
This study is testing whether non-experts can use AI-supported ultrasound to screen for breast cancer in communities with limited resources. About 4,800 women (asymptomatic from age 30, or symptomatic from age 18) will receive a clinical breast exam and AI-guided ultrasound. The goal is to see if this approach can accurately detect cancer and safely triage women for further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arba Minch University and health care facilities and markets in the Gamo Zone
RECRUITINGArba Minch, Gamo Zone, Ethiopia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.